Funder: European Commission
Due Dates: January 26, 2026 (SAMRC pre-eligibility check, South Africa) | February 10, 2026 (Pre-proposal, joint call) | February 11, 2026 (FWF national pre-proposal, Austria) | June 9, 2026 (Full proposal, invited applicants) | June 10, 2026 (FWF national full-proposal, Austria)
Funding Amounts: ~€38 million total; typical national/regional limits apply; project duration up to 3 years.
Summary: Funds transnational, multidisciplinary research advancing personalised medicine for cardiovascular, metabolic, and kidney diseases, emphasizing innovation, collaboration, and translation to healthcare.
Key Information: Two-stage application (pre-proposal/full proposal); strict eligibility and national rules; strong emphasis on consortium composition and stakeholder involvement.